ikfe-CRO GmbH

Industry · 8 registered clinical trials.

Status	Trial	Phase	Started
Completed	Effects of Linagliptin on Endothelial- , Renal-, and Retinal Function in Patients With Hypertension and Albumi Arterial Hypertension, Albuminuria	Phase 3	2013-01-01
Unknown	Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Diabetes Mellitus Type II	Phase 4	2011-11-01
Unknown	Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use Insulin-requiring Type 2 Diabetes Mellitus	Phase 4	2011-10-01
Unknown	Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of S Type 2 Diabetes Mellitus	Phase 4	2011-09-01
Completed	Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus Diabetes Mellitus, Type 2	Phase 4	2010-04-01
Unknown	Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type Diabetes Mellitus, Type 2	Phase 4	2010-02-01
Completed	Beta Cell Relieving and Cardiovascular Protective Effects of LANTUS Treatment in Type 2 Diabetes Patients Diabetes Mellitus, Type 2	—	2009-11-01
Completed	Beta-Cell Function of Insulin Glargine Compared to Neutral Protamine Hagedorn (NPH) Insuline and to Insulin De Type 2 Diabetic Patients, Insufficient Metabolic Control, OAD Treatment	Phase 4	2008-04-01